Precision medicine in multiple myeloma: are we there yet?

被引：5

作者：

Auclair, Daniel ^{[1
]}

Lonial, Sagar ^{[2
]}

Anderson, Kenneth C. ^{[3
]}

Kumar, Shaji K. ^{[4
]}

机构：

[1] Multiple Myeloma Res Fdn, Norwalk, CT USA

[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[4] Mayo Clin, Canc Ctr, Div Hematol, Rochester, MN USA

来源：

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | 2019年 / 4卷 / 02期

关键词：

THERAPIES;

D O I：

10.1080/23808993.2019.1578172

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：51 / 53

页数：3

共 15 条

[1] Promise of Immune Therapies in Multiple Myeloma [J].

Anderson, Kenneth C. .

JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (07) :411-+

[2] Targeting the BRAF V600E Mutation in Multiple Myeloma [J].

Andrulis, Mindaugas ;

Lehners, Nicola ;

Capper, David ;

Penzel, Roland ;

Heining, Christoph ;

Huellein, Jennifer ;

Zenz, Thorsten ;

von Deimling, Andreas ;

Schirmacher, Peter ;

Ho, Anthony D. ;

Goldschmidt, Hartmut ;

Neben, Kai ;

Raab, Marc S. .

CANCER DISCOVERY, 2013, 3 (08) :862-869

[3]

Barwick BG, MULTIPLE MYELOMA IMM, DOI [10.1101/340877, DOI 10.1101/340877]

[4] The Tao of myeloma [J].

Boise, Lawrence H. ;

Kaufman, Jonathan L. ;

Bahlis, Nizar J. ;

Lonial, Sagar ;

Lee, Kelvin P. .

BLOOD, 2014, 124 (12) :1873-1879

[5] Heterogeneity of genomic evolution and mutational profiles in multiple myeloma [J].

Bolli, Niccolo ;

Avet-Loiseau, Herve ;

Wedge, David C. ;

Van Loo, Peter ;

Alexandrov, Ludmil B. ;

Martincorena, Inigo ;

Dawson, Kevin J. ;

Iorio, Francesco ;

Nik-Zainal, Serena ;

Bignell, Graham R. ;

Hinton, Jonathan W. ;

Li, Yilong ;

Tubio, Jose M. C. ;

McLaren, Stuart ;

Meara, Sarah O' ;

Butler, Adam P. ;

Teague, Jon W. ;

Mudie, Laura ;

Anderson, Elizabeth ;

Rashid, Naim ;

Tai, Yu-Tzu ;

Shammas, Masood A. ;

Sperling, Adam S. ;

Fulciniti, Mariateresa ;

Richardson, Paul G. ;

Parmigiani, Giovanni ;

Magrangeas, Florence ;

Minvielle, Stephane ;

Moreau, Philippe ;

Attal, Michel ;

Facon, Thierry ;

Futreal, P. Andrew ;

Anderson, Kenneth C. ;

Campbell, Peter J. ;

Munshi, Nikhil C. .

NATURE COMMUNICATIONS, 2014, 5

[6] Initial genome sequencing and analysis of multiple myeloma [J].

Chapman, Michael A. ;

Lawrence, Michael S. ;

Keats, Jonathan J. ;

Cibulskis, Kristian ;

Sougnez, Carrie ;

Schinzel, Anna C. ;

Harview, Christina L. ;

Brunet, Jean-Philippe ;

Ahmann, Gregory J. ;

Adli, Mazhar ;

Anderson, Kenneth C. ;

Ardlie, Kristin G. ;

Auclair, Daniel ;

Baker, Angela ;

Bergsagel, P. Leif ;

Bernstein, Bradley E. ;

Drier, Yotam ;

Fonseca, Rafael ;

Gabriel, Stacey B. ;

Hofmeister, Craig C. ;

Jagannath, Sundar ;

Jakubowiak, Andrzej J. ;

Krishnan, Amrita ;

Levy, Joan ;

Liefeld, Ted ;

Lonial, Sagar ;

Mahan, Scott ;

Mfuko, Bunmi ;

Monti, Stefano ;

Perkins, Louise M. ;

Onofrio, Robb ;

Pugh, Trevor J. ;

Rajkumar, S. Vincent ;

Ramos, Alex H. ;

Siegel, David S. ;

Sivachenko, Andrey ;

Stewart, A. Keith ;

Trudel, Suzanne ;

Vij, Ravi ;

Voet, Douglas ;

Winckler, Wendy ;

Zimmerman, Todd ;

Carpten, John ;

Trent, Jeff ;

Hahn, William C. ;

Garraway, Levi A. ;

Meyerson, Matthew ;

Lander, Eric S. ;

Getz, Gad ;

Golub, Todd R. .

NATURE, 2011, 471 (7339) :467-472

[7] Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond [J].

Chim, C. S. ;

Kumar, S. K. ;

Orlowski, R. Z. ;

Cook, G. ;

Richardson, P. G. ;

Gertz, M. A. ;

Giralt, S. ;

Mateos, M. V. ;

Leleu, X. ;

Anderson, K. C. .

LEUKEMIA, 2018, 32 (02) :252-262

[8] Inhibiting MEK in MAPK pathway-activated myeloma [J].

Heuck, C. J. ;

Jethava, Y. ;

Khan, R. ;

van Rhee, F. ;

Zangari, M. ;

Chavan, S. ;

Robbins, K. ;

Miller, S. E. ;

Matin, A. ;

Mohan, M. ;

Ali, S. M. ;

Stephens, P. J. ;

Ross, J. S. ;

Miller, V. A. ;

Davies, F. ;

Barlogie, B. ;

Morgan, G. .

LEUKEMIA, 2016, 30 (04) :976-980

[9] Targeting MYC in multiple myeloma [J].

Jovanovic, K. K. ;

Roche-Lestienne, C. ;

Ghobrial, I. M. ;

Facon, T. ;

Quesnel, B. ;

Manier, S. .

LEUKEMIA, 2018, 32 (06) :1295-1306

[10] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma [J].

Kumar, Shaji ;

Kaufman, Jonathan L. ;

Gasparetto, Cristina ;

Mikhael, Joseph ;

Vij, Ravi ;

Pegourie, Brigitte ;

Benboubker, Lofti ;

Facon, Thierry ;

Amiot, Martine ;

Moreau, Philippe ;

Punnoose, Elizabeth A. ;

Alzate, Stefanie ;

Dunbar, Martin ;

Xu, Tu ;

Agarwal, Suresh K. ;

Enschede, Sari Heitner ;

Leverson, Joel D. ;

Ross, Jeremy A. ;

Maciag, Paulo C. ;

Verdugo, Maria ;

Touzeau, Cyrille .

BLOOD, 2017, 130 (22) :2401-2409

← 1 2 →